| Nome |
# |
|
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis, file e31e124e-81f9-987f-e053-3705fe0a095a
|
650
|
|
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study, file e31e124e-0f75-987f-e053-3705fe0a095a
|
579
|
|
Epidemiology of psoriatic arthritis, file e31e124e-1445-987f-e053-3705fe0a095a
|
428
|
|
Trial of Tocilizumab in Giant-Cell Arteritis, file e31e124f-08ad-987f-e053-3705fe0a095a
|
379
|
|
Follow-Up CT Patterns of Residual Lung Abnormalities in Severe COVID-19 Pneumonia Survivors: A Multicenter Retrospective Study, file e31e1250-6de5-987f-e053-3705fe0a095a
|
370
|
|
Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes, file e31e1250-7219-987f-e053-3705fe0a095a
|
354
|
|
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study, file e31e124e-0f71-987f-e053-3705fe0a095a
|
294
|
|
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology, file e31e1250-38a4-987f-e053-3705fe0a095a
|
276
|
|
Vasculitis of the gastrointestinal tract in chronic periaortitis, file e31e124d-f0f9-987f-e053-3705fe0a095a
|
272
|
|
G/R 241 polymorphism of intercellular adhesion molecule 1 (ICAM-1) is associated with Fuchs uveitis, file e31e124e-740d-987f-e053-3705fe0a095a
|
230
|
|
Clinical Spectrum of Medium-Sized Vessel Vasculitis, file e31e124e-b5c2-987f-e053-3705fe0a095a
|
229
|
|
Muscoloskeletal manifestations in inflammatory bowel disease, file e31e124e-17d1-987f-e053-3705fe0a095a
|
227
|
|
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis, file b6d814f0-c559-41e1-aeac-1f9794c2f67e
|
218
|
|
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device), file e31e124d-c220-987f-e053-3705fe0a095a
|
213
|
|
Angiography-negative primary central nervous system vasculitis: a syndrome involving small cerebral vessels, file e31e124d-f0fc-987f-e053-3705fe0a095a
|
212
|
|
Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy, file e31e124e-0f84-987f-e053-3705fe0a095a
|
203
|
|
Complex interplay between neutral and adaptive evolution shaped differential genomic background and disease susceptibility along the Italian peninsula, file e31e124e-06b4-987f-e053-3705fe0a095a
|
192
|
|
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion, file e31e124e-b86f-987f-e053-3705fe0a095a
|
191
|
|
Large-Vessel Dilatation in Giant Cell Arteritis: A Different Subset of Disease?, file e31e124e-813c-987f-e053-3705fe0a095a
|
190
|
|
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review, file e31e124e-0cb3-987f-e053-3705fe0a095a
|
188
|
|
A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility, file e31e124c-50f7-987f-e053-3705fe0a095a
|
174
|
|
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice, file e31e124e-cffb-987f-e053-3705fe0a095a
|
174
|
|
Rehabilitation Interventions for Post-Acute COVID-19 Syndrome: A Systematic Review, file e31e1250-8b85-987f-e053-3705fe0a095a
|
171
|
|
Updates on the diagnosis and monitoring of giant cell arteritis, file 45dffab0-3e50-4236-8a29-7e3097f4c6fe
|
169
|
|
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease, file e31e124f-546d-987f-e053-3705fe0a095a
|
167
|
|
Nailfold videocapillaroscopy in antisynthetase syndrome, file e31e124d-87f4-987f-e053-3705fe0a095a
|
165
|
|
VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis, file e31e1250-6964-987f-e053-3705fe0a095a
|
157
|
|
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease, file e31e124e-4484-987f-e053-3705fe0a095a
|
151
|
|
Imaging in polymyalgia rheumatica, file e31e124d-e9ec-987f-e053-3705fe0a095a
|
149
|
|
Sensing Inflammation Biomarkers with Electrolyte-Gated Organic Electronic Transistors, file e31e124f-ac4f-987f-e053-3705fe0a095a
|
148
|
|
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study, file e31e124e-09b8-987f-e053-3705fe0a095a
|
145
|
|
Increased expression of interleukin-22 in patients with giant cell arteritis, file e31e124e-dc52-987f-e053-3705fe0a095a
|
144
|
|
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming?, file e31e124e-8ab4-987f-e053-3705fe0a095a
|
143
|
|
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis, file e31e124e-fa09-987f-e053-3705fe0a095a
|
143
|
|
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis, file e31e124e-a95f-987f-e053-3705fe0a095a
|
140
|
|
Polymyalgia rheumatica: an autoinflammatory disorder?, file e31e124e-0a2f-987f-e053-3705fe0a095a
|
139
|
|
Whole Exome Sequencing Identifies Rare Protein-Coding Variants in Behçet's Disease, file e31e124e-c2e9-987f-e053-3705fe0a095a
|
138
|
|
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs, file e31e124d-e9f9-987f-e053-3705fe0a095a
|
130
|
|
The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis, file e31e1250-6de3-987f-e053-3705fe0a095a
|
127
|
|
Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor in Patients With Behçet Disease, file e31e124d-fcde-987f-e053-3705fe0a095a
|
125
|
|
Tocilizumab in patients with severe COVID-19: a retrospective cohort study, file e31e124e-979d-987f-e053-3705fe0a095a
|
125
|
|
Evidence-based algorithm for diagnosis and assessment in psoriatic arthritis: results by Italian DElphi in psoriatic Arthritis (IDEA), file e31e124d-ebff-987f-e053-3705fe0a095a
|
124
|
|
Modulation of Cell Death and Promotion of Chondrogenic Differentiation by Fas/FasL in Human Dental Pulp Stem Cells (hDPSCs), file e31e124e-3e50-987f-e053-3705fe0a095a
|
122
|
|
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial, file e31e124e-d215-987f-e053-3705fe0a095a
|
121
|
|
In memoriam: Ignazio Olivieri, file e31e124d-f59a-987f-e053-3705fe0a095a
|
120
|
|
Rituximab therapy for Takayasu arteritis: A seven patients experience and a review of the literature, file e31e124e-866f-987f-e053-3705fe0a095a
|
120
|
|
Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term Study, file e31e1250-2cab-987f-e053-3705fe0a095a
|
120
|
|
64 Cu and fluorescein labeled anti-miRNA peptide nucleic acids for the detection of miRNA expression in living cells, file e31e124e-087d-987f-e053-3705fe0a095a
|
119
|
|
[Disease activity assessment in large vessel vasculitis], file e31e124e-159a-987f-e053-3705fe0a095a
|
118
|
|
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis, file e31e124d-fc5a-987f-e053-3705fe0a095a
|
117
|
|
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status, file e31e124e-8ff2-987f-e053-3705fe0a095a
|
116
|
|
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review, file e31e124f-7bd6-987f-e053-3705fe0a095a
|
116
|
|
Flares in Biopsy-Proven Giant Cell Arteritis in Northern Italy: Characteristics and Predictors in a Long-Term Follow-Up Study, file e31e124e-0ca0-987f-e053-3705fe0a095a
|
114
|
|
Interstitial lung disease and anti-myeloperoxidase antibodies: not a simple association, file e31e124f-df88-987f-e053-3705fe0a095a
|
113
|
|
Anakinra drug retention rate and predictive factors of long-term response in systemic juvenile idiopathic arthritis and adult onset still disease, file e31e124d-fc58-987f-e053-3705fe0a095a
|
112
|
|
Idiopathic aortitis: an underrecognized vasculitis, file e31e124e-0eea-987f-e053-3705fe0a095a
|
111
|
|
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study, file e31e124e-0024-987f-e053-3705fe0a095a
|
110
|
|
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows, file e31e124e-68ad-987f-e053-3705fe0a095a
|
110
|
|
Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study, file e31e124e-b8b8-987f-e053-3705fe0a095a
|
110
|
|
Contribution of the new 2012 EULAR/ACR classification criteria for the diagnosis of polymyalgia rheumatica, file e31e124d-e992-987f-e053-3705fe0a095a
|
109
|
|
Predictors of Loss of Remission and Disease Flares in Patients with Axial Spondyloarthritis Receiving Antitumor Necrosis Factor Treatment: A Retrospective Study, file e31e124f-7698-987f-e053-3705fe0a095a
|
108
|
|
Clinical assessment in psoriatic arthritis, file e31e124e-1fd2-987f-e053-3705fe0a095a
|
105
|
|
Comment on: Rituximab therapy for takayasu arteritis: A seven patients experience and a review of the literature: Reply, file e31e124e-675b-987f-e053-3705fe0a095a
|
104
|
|
Occasional detection of thymic epithelial tumor 4 years after diagnosis of adult onset Still disease: A challenging case report and immuno-oncological considerations coming from pertinent literature review, file e31e124e-0ab0-987f-e053-3705fe0a095a
|
103
|
|
Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study, file e31e124e-01a9-987f-e053-3705fe0a095a
|
102
|
|
Anti-drug antibody detection with label-free electrolyte-gated organic field-effect transistors, file e31e124f-af57-987f-e053-3705fe0a095a
|
101
|
|
CD3 immunohistochemistry is helpful in the diagnosis of giant cell arteritis, file e31e124e-8b79-987f-e053-3705fe0a095a
|
100
|
|
TLR-4 and VEGF polymorphisms in chronic periaortitis, file e31e124e-03f4-987f-e053-3705fe0a095a
|
99
|
|
Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy, file e31e124e-06a8-987f-e053-3705fe0a095a
|
99
|
|
[Reactive arthritis: advances in diagnosis and treatment], file e31e124e-1bd3-987f-e053-3705fe0a095a
|
99
|
|
Glucocorticoid Dosages and Acute-Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab, file e31e124f-0a67-987f-e053-3705fe0a095a
|
95
|
|
An update of the Mayo Clinic cohort of patients with adult primary central nervous system vasculitis: description of 163 patients, file e31e124e-0b7e-987f-e053-3705fe0a095a
|
94
|
|
Imaging Findings of Cerebral Amyloid Angiopathy, Aβ-Related Angiitis (ABRA), and Cerebral Amyloid Angiopathy-Related Inflammation: A Single-Institution 25-Year Experience, file e31e124e-0c9f-987f-e053-3705fe0a095a
|
94
|
|
Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors, file e31e124e-b91f-987f-e053-3705fe0a095a
|
93
|
|
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis, file e31e124e-9b0c-987f-e053-3705fe0a095a
|
92
|
|
A candidate gene approach identifies an IL33 genetic variant as a novel genetic risk factor for GCA, file e31e124e-02a9-987f-e053-3705fe0a095a
|
91
|
|
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study, file e31e124f-c96d-987f-e053-3705fe0a095a
|
91
|
|
Systemic sclerosis cutaneous expression: Management of skin fibrosis and digital ulcers, file e31e124f-bd69-987f-e053-3705fe0a095a
|
87
|
|
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease, file e31e124e-b720-987f-e053-3705fe0a095a
|
86
|
|
Effectiveness of adalimumab for the treatment of psoriatic arthritis: An Italian real-life retrospective study, file e31e124e-7dce-987f-e053-3705fe0a095a
|
81
|
|
mRNA-COVID19 Vaccination Can Be Considered Safe and Tolerable for Frail Patients, file e31e1250-9872-987f-e053-3705fe0a095a
|
81
|
|
Topical Cannabidiol in the Treatment of digital ulcers in patients with Scleroderma: comparative Analysis and Literature Review, file e35a19f7-83cd-4019-b9e0-0c7fecbfdb82
|
80
|
|
Management of Systemic Sclerosis Patients in the COVID-19 Era: The Experience of an Expert Specialist Reference Center, file e31e124f-d5ec-987f-e053-3705fe0a095a
|
76
|
|
Interstitial pneumonia with autoimmune features: Why rheumatologist–pulmonologist collaboration is essential, file e31e124f-224d-987f-e053-3705fe0a095a
|
75
|
|
A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility, file e31e124d-ffe1-987f-e053-3705fe0a095a
|
74
|
|
Adult primary central nervous system vasculitis treatment and course: analysis of one hundred sixty-three patients, file e31e1250-5e0f-987f-e053-3705fe0a095a
|
74
|
|
Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritis, file e31e124f-16f9-987f-e053-3705fe0a095a
|
70
|
|
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis, file e31e124f-5c90-987f-e053-3705fe0a095a
|
70
|
|
Erratum to: Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990 consecutive cases, file e31e124f-7bdf-987f-e053-3705fe0a095a
|
70
|
|
Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis, file e31e1250-4d1b-987f-e053-3705fe0a095a
|
67
|
|
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY, file e31e124f-d5b2-987f-e053-3705fe0a095a
|
63
|
|
Extra-articular rheumatoid arthritis imaged by [18F]FDG-PET/CT, file e31e124e-14ad-987f-e053-3705fe0a095a
|
62
|
|
POS0837 THE USE OF CANNABIDIOL IN THE TREATMENT OF PAIN RELATED TO SCLERODERMA DIGITAL ULCERS, file e31e124f-dc7e-987f-e053-3705fe0a095a
|
62
|
|
AB0645 CANNABINOIDS IN THE TREATMENT OF PAIN RELATED TO SYSTEMIC SCLEROSIS SKIN ULCERS: OUR EXPERIENCE, file e31e124f-b234-987f-e053-3705fe0a095a
|
60
|
|
Do we need FDG-PET/CT to assess atherosclerosis?, file e31e124f-324e-987f-e053-3705fe0a095a
|
59
|
|
FRI0442 Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience, file e31e124f-b4e2-987f-e053-3705fe0a095a
|
58
|
|
AB0611 STRAIN ANALYSIS OF THE RIGHT VENTRICLE USING 2D-SPECKLE TRACKING ECHOCARDIOGRAPHY IN A COHORT OF PATIENTS WITH SYSTEMIC SCLEROSIS, file e31e124f-a18d-987f-e053-3705fe0a095a
|
57
|
|
AB0212 LONG-TERM TREATMENT WITH RITUXIMAB IN SYSTEMIC SCLEROSISMANAGEMENT: AN OVERVIEW OF THE CLINICAL EXPERIENCE FROM A REAL-LIFE SETTING, file e31e124f-b232-987f-e053-3705fe0a095a
|
56
|
|
Mortality Prediction of COVID-19 Patients Using Radiomic and Neural Network Features Extracted from a Wide Chest X-ray Sample Size: A Robust Approach for Different Medical Imbalanced Scenarios, file e31e1250-986a-987f-e053-3705fe0a095a
|
55
|
|
AB0760 Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution, file e31e124f-b4e0-987f-e053-3705fe0a095a
|
50
|
| Totale |
14.464 |
